SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011475
Filing Date
2022-06-10
Accepted
2022-06-10 16:07:16
Documents
13
Period of Report
2022-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K tngx-20220608.htm   iXBRL 8-K 58804
2 GRAPHIC img159113006_0.jpg GRAPHIC 778
  Complete submission text file 0000950170-22-011475.txt   184265

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tngx-20220608.xsd EX-101.SCH 2461
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tngx-20220608_lab.xml EX-101.LAB 14711
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tngx-20220608_pre.xml EX-101.PRE 11385
7 EXTRACTED XBRL INSTANCE DOCUMENT tngx-20220608_htm.xml XML 4881
Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 221008889
SIC: 2834 Pharmaceutical Preparations